- Home
- PETZ vs AIMD Comparison
PETZ vs AIMD Comparison
Compare PETZ & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PETZ | AIMD |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 10.2M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | PETZ | AIMD |
|---|---|---|
| Price | $1.11 | $2.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.5K | ★ 1.8M |
| Earning Date | 11-13-2025 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $1,046,006.00 | $113,037.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.26 | ★ N/A |
| Revenue Growth | N/A | ★ 178.19 |
| 52 Week Low | $0.65 | $1.61 |
| 52 Week High | $1.68 | $4.50 |
Technical Indicators
Market Signals| Indicator | PETZ | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.39 | 50.86 |
| Support Level | $1.04 | $1.70 |
| Resistance Level | $1.20 | $2.46 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 98.24 | 39.47 |
Price Performance
Historical ComparisonAbout PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.